Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Artru

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II studyJulien Taïeb, Pascal Artru, François Paye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2007
Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studiesFlorence Huguet, Thierry André, Pascal Hammel, et al.
BMC Cancer|June 16, 2014
FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM studyAziz Zaanan, Isabelle Trouilloud, Theofano Markoutsaki, et al.
Plos One|May 27, 2015
Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II TrialAmélie Anota, Guillaume Mouillet, Isabelle Trouilloud, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 4, 2018
RAS mutation testing in patients with metastatic colorectal cancer in French clinical practice: A status report in 2014Astrid Lièvre, Jean-Louis Merlin, Jean-Christophe Sabourin, et al.
Clinical Colorectal Cancer|October 26, 2019
Efficacy and Safety of Aflibercept in Combination With Chemotherapy Beyond Second-Line Therapy in Metastatic Colorectal Carcinoma Patients: An AGEO Multicenter StudyMarie Auvray, David Tougeron, Edouard Auclin, et al.
British Journal of Cancer|February 12, 2022
Correction to: Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO studySonia Zaibet, Vincent Hautefeuille, Edouard Auclin, et al.
JAMA|May 4, 2016
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical TrialPascal Hammel, Florence Huguet, Jean-Luc van Laethem, et al.
British Journal of Cancer|January 30, 2022
Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO studySonia Zaibet, Vincent Hautefeuille, Edouard Auclin, et al.
World Journal of Surgical Oncology|April 24, 2022
Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric studySahir Javed, Stéphane Benoist, Patrick Devos, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II studyJulien Taïeb, Pascal Artru, François Paye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2007
Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studiesFlorence Huguet, Thierry André, Pascal Hammel, et al.
BMC Cancer|June 16, 2014
FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM studyAziz Zaanan, Isabelle Trouilloud, Theofano Markoutsaki, et al.
Plos One|May 27, 2015
Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II TrialAmélie Anota, Guillaume Mouillet, Isabelle Trouilloud, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 4, 2018
RAS mutation testing in patients with metastatic colorectal cancer in French clinical practice: A status report in 2014Astrid Lièvre, Jean-Louis Merlin, Jean-Christophe Sabourin, et al.
Clinical Colorectal Cancer|October 26, 2019
Efficacy and Safety of Aflibercept in Combination With Chemotherapy Beyond Second-Line Therapy in Metastatic Colorectal Carcinoma Patients: An AGEO Multicenter StudyMarie Auvray, David Tougeron, Edouard Auclin, et al.
British Journal of Cancer|February 12, 2022
Correction to: Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO studySonia Zaibet, Vincent Hautefeuille, Edouard Auclin, et al.
JAMA|May 4, 2016
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical TrialPascal Hammel, Florence Huguet, Jean-Luc van Laethem, et al.
British Journal of Cancer|January 30, 2022
Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO studySonia Zaibet, Vincent Hautefeuille, Edouard Auclin, et al.
World Journal of Surgical Oncology|April 24, 2022
Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric studySahir Javed, Stéphane Benoist, Patrick Devos, et al.
Pageof 9